Two type 1 diabetes patients are insulin-free after Eledon’s immunosuppressant and an islet transplant

Eledon Pharmaceuticals’ experimental immunosuppressant helped two patients with type 1 diabetes go insulin-free following an islet cell transplant, the company announced Tuesday.

The company’s stock …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Price inflation tied to higher mental health service utilization among adults and elderly in England

The relationship between price elevation and psychiatric care in the British population.

May 6, 2024

FDA approves Amgen’s T cell engager in aggressive form of lung cancer

The FDA on Thursday granted accelerated approval to Amgen’s bispecific T cell engager tarlatamab in small cell lung cancer, an aggressive disease that makes up

May 17, 2024

M&A activity in the pharmaceutical industry in Germany increased in 2023

In value terms, M&A activity in Germany remained flat in Q2 2023 compared with the previous quarter and as compared to Q2 2022. Related deal

August 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.